You are here: Home > Institute of Excellence (CPD) > Calendar > CPD Events > OCT interpretation; Emerging therapies in AMD; Macular Sx Update; Patient Privacy

OCT interpretation; Emerging therapies in AMD; Macular Sx Update; Patient Privacy

Date: 28/08/2019

Venue: Campbelltown Rydges, Bookman-Rockwell room,15 Menangle road, Campbelltown , NSW, 2560

Provider: INSERVIO PTY LTD - Sponsor

Contact: INSERVIO PTY LTD, [E] Tina.Xenoulis@inservio.com.au, [P] 0432808708

Learning Objectives

  • Understand retinal pathology in an OCT
  • Explain the principles and applications of an OCT
  • Identify various common disease state by OCT testing
  • be aware of current treatment for AMD and their efficacy
  • understand the different available treatments for Dry and wet AMD
  • be aware of new treatments and their availability for AMD
  • Understand the timing and need for macular surgery
  • Determine the urgency of referral for macular surgery
  • Understand available options and patient information for macular surgery
  • List ways that health care workers can protect their patients’ personal information.
  • Define the requirements of notifiable data breaches for certain types of breaches involving patient personal information.
  • Identify the leading cause of data breaches in the Australian private health care sector.

Max points awarded: 6.67

Session Information

Name
OCT interpretations
Activity Type
Face to Face with Assessment
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.00
Name
Emerging therapies in AMD
Activity Type
Face to Face with Assessment
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.00
Name
Macular Sx Update
Activity Type
Face to Face with Assessment
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.00
Name
Patient privacy and the Australian health care sector
Activity Type
Non Clinical
Therapeutic?
No
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
0.67

NameActivity TypeTherapeutic?Manufacturer/
Supplier?
Points for attending &
Passing Assessment
OCT interpretationsFace to Face with AssessmentNoNo2.00
Emerging therapies in AMDFace to Face with AssessmentNoNo2.00
Macular Sx UpdateFace to Face with AssessmentNoNo2.00
Patient privacy and the Australian health care sectorNon ClinicalNoNo0.67